Tianan Pharmaceutical Co Stock Price To Earning
| TNPH Stock | USD 0.01 0.00 0.00% |
Tianan Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianan Pink Sheet. The fundamental analysis module provides a way to measure Tianan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianan Pharmaceutical pink sheet.
Tianan |
Tianan Pharmaceutical Co Company Price To Earning Analysis
Tianan Pharmaceutical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Tianan Pharmaceutical Price To Earning | 0.15 X |
Most of Tianan Pharmaceutical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianan Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Tianan Pharmaceutical Co has a Price To Earning of 0.15 times. This is 99.42% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all United States stocks is 99.48% higher than that of the company.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Tianan Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| Gross Profit | 7.3 M | |||
| EBITDA | 4.31 M | |||
| Net Income | 3.14 M | |||
| Cash And Equivalents | 8.23 M | |||
| Cash Per Share | 0.59 X | |||
| Current Ratio | 14.23 X | |||
| Book Value Per Share | 1.03 X | |||
| Cash Flow From Operations | 2.56 M | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.86 | |||
| Market Capitalization | 17.29 M | |||
| Total Asset | 15.38 M | |||
| Retained Earnings | 4.96 M | |||
| Working Capital | 11.29 M | |||
| Current Asset | 12.14 M | |||
| Current Liabilities | 853 K | |||
| Net Asset | 15.38 M |
About Tianan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tianan Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tianan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tianan Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tianan Pink Sheet
Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.